Brii Biosciences-B (02137) announces the launch of the BRiSC siRNA drug R&D platform

Zhito Finance APP News: Brii Biosciences-B (02137) has announced the launch of its independently developed BRiSC (Bispecific RNAi SilenCing) small interfering ribonucleic acid (siRNA) drug discovery platform to advance the development of next-generation ribonucleic acid (RNA) therapies.